Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

IMPORTANCE: Transcatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for severe aortic stenosis in patients who cannot undergo surgery and for patients at high operative risk. Use of TAVR for off-label indications has not been previously reported. OBJECTIVE:...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:JAMA Cardiol
मुख्य लेखकों: Hira, Ravi S., Vemulapalli, Sreekanth, Li, Zhuokai, McCabe, James M., Rumsfeld, John S., Kapadia, Samir R., Alam, Mahboob, Jneid, Hani, Don, Creighton, Reisman, Mark, Virani, Salim S., Kleiman, Neal S.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Medical Association 2017
विषय:
Original Investigation
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710589/
https://ncbi.nlm.nih.gov/pubmed/28636718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.1685
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन